Подписаться
Moshe Elkabets
Moshe Elkabets
Prof. at the Ben-Gurion University of the Negev
Подтвержден адрес электронной почты в домене bgu.ac.il - Главная страница
Название
Процитировано
Процитировано
Год
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
RN Apte, S Dotan, M Elkabets, MR White, E Reich, Y Carmi, X Song, ...
Cancer and Metastasis Reviews 25, 387-408, 2006
7302006
Interleukin-1β–Driven inflammation promotes the development and invasiveness of chemical carcinogen–Induced tumors
Y Krelin, E Voronov, S Dotan, M Elkabets, E Reich, M Fogel, M Huszar, ...
Cancer research 67 (3), 1062-1071, 2007
3832007
IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and function
M Elkabets, VSG Ribeiro, CA Dinarello, S Ostrand‐Rosenberg, ...
European journal of immunology 40 (12), 3347-3357, 2010
3812010
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
M Elkabets, E Pazarentzos, D Juric, Q Sheng, RA Pelossof, S Brook, ...
Cancer cell 27 (4), 533-546, 2015
3242015
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
M Elkabets, S Vora, D Juric, N Morse, M Mino-Kenudson, T Muranen, ...
Science translational medicine 5 (196), 196ra99-196ra99, 2013
3202013
Effects of micro-environment-and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour–host interactions
RN Apte, Y Krelin, X Song, S Dotan, E Recih, M Elkabets, Y Carmi, ...
European journal of cancer 42 (6), 751-759, 2006
2912006
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
E Toska, HU Osmanbeyoglu, P Castel, C Chan, RC Hendrickson, ...
Science 355 (6331), 1324-1330, 2017
2782017
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
M Elkabets, AM Gifford, C Scheel, B Nilsson, F Reinhardt, MA Bray, ...
The Journal of clinical investigation 121 (2), 784-799, 2011
2532011
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
Y Shamay, M Elkabets, H Li, J Shah, S Brook, F Wang, K Adler, E Baut, ...
Science translational medicine 8 (345), 345ra87-345ra87, 2016
2072016
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer
JJ Tao, P Castel, N Radosevic-Robin, M Elkabets, N Auricchio, N Aceto, ...
Science signaling 7 (318), ra29-ra29, 2014
1702014
Unique versus redundant functions of IL-1α and IL-1β in the tumor microenvironment
E Voronov, S Dotan, Y Krelin, X Song, M Elkabets, Y Carmi, P Rider, ...
Frontiers in immunology 4, 177, 2013
1602013
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis
Y Carmi, G Rinott, S Dotan, M Elkabets, P Rider, E Voronov, RN Apte
The Journal of Immunology 186 (6), 3462-3471, 2011
1392011
Molecular pathways: AXL, a membrane receptor mediator of resistance to therapy
M Scaltriti, M Elkabets, J Baselga
Clinical Cancer Research 22 (6), 1313-1317, 2016
1292016
Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin
G Sarfati, T Dvir, M Elkabets, RN Apte, S Cohen
Biomaterials 32 (1), 152-161, 2011
952011
Sialylation of 3-methylcholanthrene–induced fibrosarcoma determines antitumor immune responses during immunoediting
M Cohen, M Elkabets, M Perlmutter, A Porgador, E Voronov, RN Apte, ...
The Journal of Immunology 185 (10), 5869-5878, 2010
862010
IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice
E Voronov, S Dotan, L Gayvoronsky, RM White, I Cohen, Y Krelin, ...
International immunology 22 (4), 245-257, 2010
802010
Differential effects of monastrol in two human cell lines
I Leizerman, R Avunie-Masala, M Elkabets, A Fich, L Gheber
Cellular and Molecular Life Sciences CMLS 61, 2060-2070, 2004
702004
Genomic landscape of pancreatic adenocarcinoma in younger versus older patients: does age matter?
I Ben-Aharon, M Elkabets, R Pelossof, KH Yu, CA Iacubuzio-Donahue, ...
Clinical Cancer Research 25 (7), 2185-2193, 2019
652019
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy
M Badarni, M Prasad, N Balaban, J Zorea, KM Yegodayev, BZ Joshua, ...
JCI insight 4 (8), e125341, 2019
602019
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk
S Elhaik-Goldman, D Kafka, R Yossef, U Hadad, M Elkabets, ...
PloS one 6 (8), e23472, 2011
552011
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20